Samuel Tanner

Dr. Samuel Tanner

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
STSamuel Tanner
Samuel Tanner
ACAhson Chaudhry
Ahson Chaudhry
NGNavneet Goraya
Navneet Goraya
RBRohan Badlani
Rohan Badlani
AJAsad Jehangir
Asad Jehangir
HPHenry Parkman
Henry Parkman
Patients with chronic constipation who do not respond to initial treatments often need further evaluation for dyssynergic defecation (DD) and slow transit constipation (STC). The aims of this study are to characterize the prevalence of DD and STC in patients referred to a motility center with chronic constipation and correlate diagnoses of DD and STC to patient demographics, medical history, and symptoms. High-resolution ARM (HR-ARM), balloon expulsion testing (BET) and whole gut transit scintigraphy (WGTS) of consecutive patients with chronic constipation were reviewed. Patients completed questionnaires describing their medical history and symptoms at the time of testing. A total of 230 patients completed HR-ARM, BET, and WGTS. Fifty (22%) patients had DD, and 127 (55%) patients had STC. Thirty patients (13%) had both DD and STC. There were no symptoms that were suggestive of STC vs. DD; however, patients with STC and DD reported more severe constipation than patients with normal transit and anorectal function. Patients with chronic constipation often need evaluation for both DD and STC to better understand their pathophysiology of symptoms and help direct treatment.

5 February 2023 in Neurogastroenterology & Motility
Verified
Journal Article
Closed access
STSamuel Tanner
Samuel Tanner
HMHelen Burton Murray
Helen Burton Murray
TBTiffany A. Brown
Tiffany A. Brown
ZMZubair Malik
Zubair Malik
HPHenry Parkman
Henry Parkman

28 September 2022 in Inflammatory Bowel Diseases
Verified
Journal Article
Closed access
PDF file
STSamuel Tanner
Samuel Tanner
JKJeffry Katz
Jeffry Katz
FCFabio Cominelli
Fabio Cominelli
MRMiguel Regueiro
Miguel Regueiro
GCGregory Cooper
Gregory Cooper
EMEmad Mansoor
Emad Mansoor
This article describes the prevalence of inflammatory bowel disease in patients with gastritis, duodenitis, and peptic ulcer disease, stratified by Helicobacter pylori infection. Inflammatory boweld is less prevalent in patients with H. pylori, and no increased risk of IBD is seen after H. pylori eradication therapy.

9 August 2025 in Pancreatology
Verified
Journal Article
Open access
JMJorge D. Machicado
Jorge D. Machicado
STSamuel Tanner
Samuel Tanner
DADayyan Adoor
Dayyan Adoor
JCJean Chalhoub
Jean Chalhoub
BPBrendan Plann-Curley
Brendan Plann-Curley
FWField F. Willingham
Field F. Willingham
The efficacy of endoscopic ultrasound-guided celiac plexus block (EUS-CPB) for treatment of pain in chronic pancreatitis (CP) is unclear. Therefore, we aimed to assess this outcome using a systematic review and meta-analysis. We conducted a comprehensive search of MEDLINE, EMBASE, and Cochrane Central for evaluating the efficacy of EUS-CPB for pain in CP. We evaluated: A) overall efficacy of EUS-CPB (defined as proportion of patients with any pain relief); B) duration of pain relief; C) efficacy of EUS-CPB at 4, 8, 12, and 26 weeks post-procedurally; and D) adverse events. A proportional meta-analysis was performed using the logit transformation. Outcomes were pooled using a random-effects model. 11 studies encompassing 729 patients met inclusion and exclusion criteria. The overall efficacy of EUS-CPB was 53% (95% CI 39-67%, I2 = 91%). The mean duration of pain relief was 81 days (95% CI 30-217, I2 = 96%). The efficacy of EUS-CPB at 4 weeks was 52% (95% CI 22-81%, I2 = 90%), at 8 weeks was 57% (95% CI 48-66%, I2 = 0%), at 12 weeks was 19% (95% CI 12-27%, I2 = 68%), and at 26 weeks was 3% (95% CI 1-8%, I2 = 0%). The prevalence of adverse events was 8% (95% CI 4-15%, I2 = 67%). EUS-CPB provides pain relief in 53% of patients with painful CP and the effect lasts on average for 3 months. A sham-controlled clinical trial is needed to determine the analgesic efficacy of EUS-CPB for pain in CP.

24 November 2025 in United European Gastroenterology Journal
Verified
Journal Article
Open access
STSamuel Tanner
Samuel Tanner
PDPriyata Dutta
Priyata Dutta
EQElit Quingalahua
Elit Quingalahua
JCJean M. Chalhoub
Jean M. Chalhoub
FHFadi Hawa
Fadi Hawa
JMJorge D Machicado
Jorge D Machicado
Background: Intraductal papillary mucinous neoplasms with low‐grade dysplasia (IPMNs w/LGD) and benign cysts, including serous cystadenomas (SCAs), are common pancreatic cystic lesions (PCLs) that are better managed conservatively. The burden of patients who undergo surgical resection for these cysts is unknown. Our study aims to estimate the global prevalence of surgical resections for IPMNs w/LGD and benign cysts, as well as the pre‐operative misclassification rate among all resected PCLs. Methods: We searched the literature through September 2023 to identify full‐text articles that reported the surgical histopathology of resected PCLs. A proportional meta‐analysis was performed using a random‐effects model, with prevalence estimates reported as pooled proportions. Subgroup analysis and meta‐regression were performed based on use of endoscopic ultrasound (EUS), years of enrollment, and geographic location. Results: Sixteen studies ( n = 5830) were identified. Among all surgically resected PCLs, 24% were IPMNs w/LGD (95% CI: 18%–32%), 16% were SCAs (95% CI 13%–19%), 4% were other benign cysts (95% CI: 3%–6%), and 24% were pre‐operatively misclassified (95% CI: 16%–34%). Of the resected IPMNs, 62% had LGD (95% CI: 51%–71%). An increasing use of pre‐operative EUS is associated with a lower prevalence of resected SCAs ( p < 0.05) but has not impacted the rate of resections for IPMNs w/LGD. The pre‐operative misclassification of PCLs has significantly decreased over time ( p < 0.01), although not significantly influenced by increasing EUS utilization or geographic location. Conclusion: One quarter of PCLs are pre‐operatively misclassified and ∼44% are surgically resected for benign cysts or IPMNs w/LGD. Implementation of advanced diagnostic tools might improve pre‐operative classification and reduce overtreatment of PCLs.

25 November 2020 in BMC Medical Research Methodology
Verified
Journal Article
Open access
PDF file
HZHuaqing Zhao
Huaqing Zhao
STSamuel Tanner
Samuel Tanner
SGSherita H. Golden
Sherita H. Golden
SFSusan G. Fisher
Susan G. Fisher
DRDaniel J Rubin
Daniel J Rubin
Background: There is little consensus on how to sample hospitalizations and analyze multiple variables to model readmission risk. The purpose of this study was to compare readmission rates and the accuracy of predictive models based on different sampling and multivariable modeling approaches. Methods: We conducted a retrospective cohort study of 17,284 adult diabetes patients with 44,203 discharges from an urban academic medical center between 1/1/2004 and 12/31/2012. Models for all-cause 30-day readmission were developed by four strategies: logistic regression using the first discharge per patient (LR-first), logistic regression using all discharges (LR-all), generalized estimating equations (GEE) using all discharges, and cluster-weighted (CWGEE) using all discharges. Multiple sets of models were developed and internally validated across a range of sample sizes. Results: The readmission rate was 10.2% among first discharges and 20.3% among all discharges, revealing that sampling only first discharges underestimates a population’s readmission rate. Number of discharges was highly correlated with number of readmissions (r = 0.87, P < 0.001). Accounting for clustering with GEE and CWGEE yielded more conservative estimates of model performance than LR-all. LR-first produced falsely optimistic Brier scores. Model performance was unstable below samples of 6000–8000 discharges and stable in larger samples. GEE and CWGEE performed better in larger samples than in smaller samples. Conclusions: Hospital readmission risk models should be based on all discharges as opposed to just the first discharge per patient and utilize methods that account for clustered data.